Lone Pine Capital - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.

Quarter-by-quarter ownership
Lone Pine Capital ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2021$229,040,000
+21.2%
1,436,9810.0%0.77%
+26.8%
Q2 2021$189,035,000
+2.1%
1,436,9810.0%0.61%
-9.5%
Q1 2021$185,198,000
+24.1%
1,436,981
+60.6%
0.67%
+24.2%
Q4 2020$149,190,000894,5330.54%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 10,719,555$1,003,779,13019.76%
Q Global Advisors, LLC 285,000$26,68717.16%
Finepoint Capital LP 163,772$15,335,6107.64%
Avoro Capital Advisors LLC 3,670,000$343,658,8005.36%
Spyglass Capital Management LLC 614,618$57,552,8304.51%
Sofinnova Investments, Inc. 754,032$70,607,5564.45%
Saturn V Capital Management LP 112,473$10,531,9724.41%
DAFNA Capital Management LLC 136,212$12,754,8923.97%
ARS Investment Partners, LLC 285,918$26,773,3623.32%
Ghost Tree Capital, LLC 85,000$7,959,4002.62%
View complete list of ASCENDIS PHARMA A/S shareholders